Picture of Vaxil Bio logo

VXL — Vaxil Bio News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: Vaxil Provides Update On Research Activities And Management Changes

Aug 2 (Reuters) - Vaxil Bio Ltd  VXL.V :
    * VAXIL PROVIDES UPDATE ON RESEARCH ACTIVITIES AND
MANAGEMENT
CHANGES
    * VAXIL BIO LTD -  EFFECTIVE JULY 31, YUVAL AVNIR, COMPANY'S
CEO
WILL BE REPLACED BY MR. GADI LEVIN, COMPANY'S CURRENT
CHAIRPERSON OF BOARD AND CFO
    * VAXIL BIO LTD - EFFECTIVE JULY 31, APPOINTMENT OF ALAN
ROOTENBERG, AS COMPANY'S CFO
    * VAXIL BIO LTD - ROOTENBERG WILL BE REPLACING GADI LEVIN,
WHO
TRANSITIONS FROM CFO POSITION TO CEO POSITION
    * VAXIL BIO LTD - ACTIVELY EXPLORING STRATEGIC OPTIONS FOR
MAXIMIZING SHAREHOLDER VALUE FROM VAXIL'S ASSETS

Source text for Eikon:  ID:nGNXbSvLnN 
Further company coverage:  VXL.V 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Vaxil Bio

See all news